Ann Moyer

Dr. Ann Moyer

Mayo Clinic
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2018 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
MRMary V. Relling
Mary V. Relling
Matthias SchwabMatthias Schwab
Matthias Schwab
MWMichelle Whirl‐Carrillo
Michelle Whirl‐Carrillo
GSGuilherme Suarez‐Kurtz
Guilherme Suarez‐Kurtz
CPChing‐Hon Pui
Ching‐Hon Pui
JYJun Yang
Jun Yang

1 September 2019 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
VPVictoria Pratt
Victoria Pratt
LCLarisa H. Cavallari
Larisa H. Cavallari
ATAndria L. Del Tredici
Andria L. Del Tredici
HHHouda Hachad
Houda Hachad
YJYuan Ji
Yuan Ji
KWKaren E. Weck
Karen E. Weck


29 April 2020 in Cell Research
Verified
Journal Article
Open access
PDF file
JYJia Yu
Jia Yu
BQBo Qin
Bo Qin
Ann MoyerAnn Moyer
Ann Moyer
SNSomaira Nowsheen
Somaira Nowsheen
XTXinyi Tu
Xinyi Tu
LWLiewei Wang
Liewei Wang
Programmed death ligand-1 (PD-L1 or B7-H1) is well known for its role in immune checkpoint regulation, but its function inside the tumor cells has rarely been explored. Here we report that nuclear PD-L1 is important for cancer cell sister chromatid cohesion. We found that depletion of PD-L1 suppresses cancer cell proliferation, colony formation in vitro, and tumor growth in vivo in immune-deficient NSG mice independent of its role in immune checkpoint. Specifically, PD-L1 functions as a subunit of the cohesin complex, and its deficiency leads to formation of multinucleated cells and causes a defect in sister chromatid cohesion. Mechanistically, PD-L1 compensates for the loss of Sororin, whose expression is suppressed in cancer cells overexpressing PD-L1. PD-L1 competes with Wing Apart-Like (WAPL) for binding to PDS5B, and secures proper sister chromatid cohesion and segregation. Our findings suggest an important role for nuclear PD-L1 in cancer cells independent of its function in immune checkpoint.

5 July 2023 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
VPVictoria Pratt
Victoria Pratt
LCLarisa H. Cavallari
Larisa H. Cavallari
MFMakenzie L. Fulmer
Makenzie L. Fulmer
AGAndrea Gaedigk
Andrea Gaedigk
HHHouda Hachad
Houda Hachad
KWKaren E. Weck
Karen E. Weck

28 September 2023 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
ATAmy J. Turner
Amy J. Turner
CNCharity Nofziger
Charity Nofziger
BRBronwyn E. Ramey
Bronwyn E. Ramey
RLReynold C. Ly
Reynold C. Ly
CBChad Bousman
Chad Bousman
AGAndrea Gaedigk
Andrea Gaedigk